The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...

The incidence of NHL is greatly increased in HIV-infected individuals; malignant lymphoma is the second ... understanding of the etiology and pathogenesis of NHL in the setting of HIV infection.

Up to one-third of all people with non-Hodgkin's lymphoma have diffuse large B-cell lymphoma (DLBCL). DLBCL grows quickly, but it's possible to cure it. Most people learn they have this type after ...

Non-Hodgkin lymphoma is the 11th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2017-2019).[1-4] In females in the UK, non-Hodgkin lymphoma is the 11th most ...

The specific treatment course and prognosis for T-cell lymphoma depends on the subtype — of which there are many — and how advanced the cancer is. Hodgkin lymphoma involves a type of cancer ...

Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

The survival rate of non-Hodgkin’s lymphoma is generally lower than that of Hodgkin’s lymphoma, but it’s still often curable. Lymphoma is a group of cancers that start in the lymphatic system.

Non-Hodgkin’s lymphoma (NHL) is a cancer found in white blood cells called lymphocytes. After diagnosis, your doctor can stage your NHL. Staging helps determine how far the cancer has spread and ...

Evidence that smoking causes non-Hodgkin’s lymphoma is mixed. However, smoking might create molecules that could prevent the destruction of cancerous cells. In general, smoking increases the ...